se of dexamethasone and clomiphene citrate in patients with polycystic ovarian syndrome resistant to clomiphene citrate
Phase 2
- Conditions
- Polycystic ovarian syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT138807041760N2
- Lead Sponsor
- Vice Chancellor for Research and Technology, Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
having PCOS according to the Rotterdam criteria for diagnosis of PCOS, age between 18 and 35 years, period of infertility >1/5 years and normal DHEAS levels. Exclusion criteria: hyperprolactinaemia, hypercorticism or thyroidism, pelvic pathology or surgery, infertility factor other than anovulation.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ovulation. Timepoint: 36-48 hr after HCG injection. Method of measurement: fluid in the cul-de-sac or corpus luteum formation, disappearance of pre-ovulatory follicle.;Pregnancy. Timepoint: 25 days after HCG administration. Method of measurement: transvaginal ultrasound examination.
- Secondary Outcome Measures
Name Time Method umber of matured follicles. Timepoint: 12-18 days after first of menstuaration. Method of measurement: sonography.